2019
DOI: 10.15562/ism.v10i1.362
|View full text |Cite
|
Sign up to set email alerts
|

Analisis rasio netrofil limfosit dan rasio platelet limfosit terhadap penanda gangguan ginjal pada penyakit systemic lupus erythematosus di RSUP dr. Wahidin Sudirohusodo tahun 2017-2018

Abstract: Background: Systemic Lupus Erythematosus (SLE) is an autoimmune disease that causes damage to several organ systems including the kidneys. The neutrophil-lymphocyte ratio (NLR) and the platelet-lymphocyte ratio (PLR) continue to be developed as a marker of SLE disease activity. This study aimed to assess NLR and PLR for markers of kidney disorders in SLE. Method: A retrospective study evaluated NLR and PLR with routine urine results including proteinuria, hematuria, and casts from 40 subjects of SLE patients a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 1 publication
(1 reference statement)
0
1
0
Order By: Relevance
“…Limfosit merupakan sistem imun adaptif yang berhubungan dengan kondisi kesehatan pasien terkait terganggunya fungsi sistem imun seperti infeksi virus COVID-19. Penelitian ini menjelaskan bahwa limfosit sebagai penanda respon inflamasi memainkan peranan penting dalam mekanisme patogenesis COVID-19 dan limfosit yang menurun dapat menyebabkan kematian (Lauddin et al, 2019).…”
Section: Hasilunclassified
“…Limfosit merupakan sistem imun adaptif yang berhubungan dengan kondisi kesehatan pasien terkait terganggunya fungsi sistem imun seperti infeksi virus COVID-19. Penelitian ini menjelaskan bahwa limfosit sebagai penanda respon inflamasi memainkan peranan penting dalam mekanisme patogenesis COVID-19 dan limfosit yang menurun dapat menyebabkan kematian (Lauddin et al, 2019).…”
Section: Hasilunclassified
“…Increased PLR is thought to be a predictor of long-term mortality and not just a marker of acute medical conditions. [15][16][17][18][19][20][21] In addition, PLR is considered inexpensive and results are quickly obtained and helps determine high-risk patients and also to follow up on clinical improvement objectively and to predict mortality in patients. 17,22 In sepsis, mostly 28 days leading to mortality is considered the most appropriate and a significant endpoint, and is widely used in clinical trials.…”
Section: Introductionmentioning
confidence: 99%